University of Ioannina
Μελέτη εξωεντερικών εκδηλώσεων των ασθενών με ιδιοπαθή φλεγμονώδη πάθηση των εντέρων στη Βορειοδυτική Ελλάδα
Abstract
dc:descriptionBackground: Patients with Inflammatory Bowel Disease (IBD) may show often various intraintestinaland extraintestinal disorders. Patients treated with methotrexate experience quite often oculardisorders that need a special attention. Anti-TNFa medications represent the first effective biologictherapy for IBD that has largely revolutionized treatment.Aim: The aim of the current study was the recording of the ocular disorders in patients with IBD treatedwith methotrexate. Also this study tried to quantify the risk of MM and other skin cancers amongpatients from Northern Greece area with IBD who take immunosuppressive or biologic anti-TNFmedications.Methodology: The current study was conducted during a 3-year period (2014-2016). Clinical historyand metabolic data of all patients were extracted from the IBD database that is kept since 1980. 101patients with IBD from Northwestern Greece, were studied. In the study 29 patients(by methotrexatetherapy) were enrolled that fulfilled the inclusion criteria and were followed in various departments ofNorthwestern Greece.Results: Subjects participating in the study (n=29), 11 were women and 18 were men. UC was evidentin 14 patients and CD in 15 patients. Visual acuity examination revealed no difference in visual acuitybetween right and left eyes in our sample. In funduscopic evaluation, maculopathy was evident in onepatient and pigmental disorders also in one patient. Anterior eye examination showed that 10.4% (n=3)of patients suffered from cataract and 20,6% ( n=6) had a Posterior Chamber Intraocular Lens (IOL)implanted in at least one eye. The mean age of enrolled patients was 44.2±15.9 years old ranging from17 years to 77 years old. No sun burn was reported from the 44.6% of the patients, 53.5% presentedmild reticular veins in the face, and lack of any elastosis was noticed in 60.4%. The occurrence of twocases with squamous and basal cell carcinoma is an important finding. The absence of any case withMM should not quiet down but should strengthen our efforts for further implementation of preventivemeasures.Conclusion: Patients with IBD in general but also those treated with methotrexate may suffer fromsignificant ocular disorders, a finding that renders their systematic follow-up from an ophthalmologist ofutmost importance for the prevention of these complications. Furthermore, education of patients toavoid deleterious sun exposure may help decrease MM incidence.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2018
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Giagkou, Eftychia
- Γιάγκου, Ευτυχία
Subjects
dc:subject × 23- ΙΦΝΕ
- ΕΚ
- ΝΚ
- Καταρράκτης
- Ωχροπάθεια
- Μεθοτρεξάτη
- Anti-TNF παράγοντες
- Δερματικός καρκίνος
- Κακοήθες μελάνωμα
- IBD
- Crohn's disease
- Ulcerative colitis
- Ocular disorders
- Methotrexate
- Skin cancer
- Anti-TNFa
- Malignant melanoma
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Επιστήμες Υγείας
- Medical and Health Sciences
- Clinical Medicine
- Health Sciences
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/43929